List of Studies ( Metabolite:12-Aminododecanoic acid)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST002283 | AN003728 | The “ForensOMICS” approach to forensic post-mortem interval estimation: combining metabolomics, lipidomics and proteomics for the analysis human skeletal remains | Bone | Human | University of Central Lancashire | Area integration | |
ST002016 | AN003284 | Metabolomics of COVID patients | Blood | Human | COVID-19 | University of Virginia | intensity |
ST000221 | AN000329 | Normal plasma cells,Low proliferation multiple myeloma and High proliferation multiple myeloma cells | Bone marrow | Human | Cancer | Mayo Clinic | Peak area |
ST001828 | AN002965 | Nested case–control study of environmental exposure within the ongoing Puerto Rico Testsite for Exploring Contamination Threats (PROTECT) pregnancy cohort. | Blood | Human | University of Michigan | Peak area | |
ST000421 | AN000665 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
ST000422 | AN000669 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
ST000551 | AN000841 | Investigating large scale metabolomics in mice tissue lacking insulin receptors and IGF-1 receptors | Muscle | Mouse | Diabetes | Mayo Clinic | Peak intensity |
ST000551 | AN000842 | Investigating large scale metabolomics in mice tissue lacking insulin receptors and IGF-1 receptors | Muscle | Mouse | Diabetes | Mayo Clinic | Peak intensity |
ST001527 | AN002549 | Lung cancer metabolomics analysis | Tumor cells | Human | Cancer | University of Louisville | Peak intensity |
ST002094 | AN003420 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
ST000046 | AN000076 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
ST000046 | AN000077 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
ST000047 | AN000080 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |